Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate
https://www.fool.com/investing/2024/06/03/watch-out-wegovy-here-comes-another-promising-anti/?source=iedfolrf0000001
Jun 03, 2024 - The fight for dominance in the weight loss market is just getting started.
0
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
https://www.fool.com/investing/2024/06/01/this-biggest-risk-for-eli-lilly-and-novo-nordisk/?source=iedfolrf0000001
Jun 01, 2024 - These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.
0
Top Research Reports for Eli Lilly, T-Mobile & BHP
https://www.zacks.com/commentary/2282096/top-research-reports-for-eli-lilly-t-mobile-bhp?cid=CS-ZC-FT-research_daily-2282096
May 31, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group Limited (BHP).
0
A New Name in Weight Loss Drugs
https://www.fool.com/investing/2024/05/28/a-new-name-in-weight-loss-drugs/?source=iedfolrf0000001
May 28, 2024 - Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
0
10 Best Vanguard Funds to Buy Right Now
https://www.fool.com/investing/2024/05/27/10-best-vanguard-funds-to-buy-right-now/?source=iedfolrf0000001
May 27, 2024 - These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
0
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
https://www.zacks.com/stock/news/2279236/eli-lilly-lly-to-ramp-up-indiana-site-for-mounjaro-zepbound?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2279236
May 27, 2024 - Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.
0
3 Blue Chip Stocks That You Can Buy and Hold for Years
https://www.fool.com/investing/2024/05/23/3-blue-chip-stocks-that-you-can-buy-and-hold-for-y/?source=iedfolrf0000001
May 23, 2024 - You won't be taking on much risk by investing in these stalwarts.
0
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
https://www.zacks.com/stock/news/2277543/lilly-lly-hits-record-high-on-crohn-s-disease-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2277543
May 22, 2024 - Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
0
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
https://www.zacks.com/stock/news/2277076/play-these-new-etfs-to-tap-lucrative-weight-loss-drug-market?cid=CS-ZC-FT-etf_news_and_commentary-2277076
May 22, 2024 - Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight management now makes the industry a thriving one.
0
Top Research Reports for Microsoft, Eli Lilly & Costco
https://www.zacks.com/commentary/2275480/top-research-reports-for-microsoft-eli-lilly-costco?cid=CS-ZC-FT-research_daily-2275480
May 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
0